 GERMANTOWN, Md., Dec. 15, 2020 PRNewswire -- Precigen, Inc. Nasdaq: PGEN, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today held an RD virtual event to provide an update on the latest progress for... 